- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04087083
Innovative Models in the Rehabilitation of the Elderly With Stroke Through Technological Innovation
Assistive Robotic in the Elderly: Innovative Models in the Rehabilitation of the Elderly With Stroke Through Technological Innovation
Study Overview
Status
Intervention / Treatment
Detailed Description
Stroke is a leading cause of disability, injury, and death in elderly people and represents a major public health problem with substantial medical and economic consequences. The incidence of stroke rapidly increases with age, doubling for each decade after age 55 years. Gait impairment is one of the most important problems after stroke and improve walking function is often a key component of any rehabilitation program. To achieve this goal, robotic gait trainer seems to be promising. In fact, some studies underline the efficacy of robotic gait training based on end-effector technology, for different diseases, in particular in stroke patients. In this randomized controlled trial, we verify the efficacy of the robotic treatment in terms of improving the gait and reducing the risk of falling and its long-term effects.
In this single blind randomized controlled trial the investigators will include 150 elderly subacute stroke patients divided in two groups to receive a traditional rehabilitation program or a robotic rehabilitation using G-EO system, an end-effector device for the gait rehabilitation, in addition to the traditional therapy. A 20 treatment sessions will be conducted, divided into 3 training sessions per week, for 7 weeks. The control group will perform traditional therapy sessions lasting 50 minutes. The technological intervention group, using G-EO system, will carry out 30 minutes of traditional therapy and 20 minutes of treatment with a robotic system. The primary outcome of the study is the evaluation of the falling risk. Secondary outcomes are the assessment of the gait improvements and the fear of falling. Further evaluations, such as length and asymmetry of the step, walking and functional status, acceptance of the technology, will be carried.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Roberta Bevilacqua
- Phone Number: 00390718004767
- Email: r.bevilacqua@inrca.it
Study Locations
-
-
-
Ancona, Italy, 60131
- Recruiting
- IRCCS INRCA Hospital
-
Contact:
- Elvira Maranesi
- Email: e.maranesi@inrca.it
-
Principal Investigator:
- Giovanni R Riccardi, MD
-
Fermo, Italy
- Not yet recruiting
- IRCCS INRCA Hospital
-
Contact:
- Valentina Di Donna
- Email: v.didonna@inrca.it
-
Principal Investigator:
- Pietro Scendoni, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Capacity to consent
- Ischemic or hemorrhagic stroke within 3 months to the recruitment, proven by computerized axial tomography or nuclear magnetic resonance
- Functional Ambulation Category (FAC) score ≤ 2
- Ranking scale score ≤ 3
- Complete communication and comprehension skills, assessed during the objective examination
- Ability to stand upright, supported or unsupported, for 1 minute
Exclusion Criteria:
- Concomitant participation in other studies
- Severe hypertonus of the hip, knee, ankle of the paretic leg with a modified Ashworth scale score ≥3
- Severe hip, knee or ankle contracture or orthopedic problem affecting ambulation that would preclude passive range of motion of the paretic leg
- Deep vein thrombosis of the lower limbs
- Other cognitive, motor and sensory deficits that negatively condition robotic training
- Treatment of spasticity of the lower limb within 3 months to the start of the study or during the study
- Lack of written informed consent
- Clinical dementia rating (CDR) score ≥ 3
- Severe systemic diseases with life expectancy < 1 year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: technological intervention arm
Twenty technological treatment sessions divided into 3 training sessions per week for 7 weeks.
|
Each session will include 30 minutes of traditional physical rehabilitation therapy followed by 20 minutes of robotic training (G-EO system, Reha Technology, Switzerland), an end-effector technology that simulates floor walking and stairs climbing (up and down)
|
|
Active Comparator: Control arm
Twenty traditional treatment sessions divided into 3 training sessions per week for 7 weeks.
|
Each session will include 50 minutes of traditional physical rehabilitation therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
difference in falling risk between experimental arm and control arm
Time Frame: before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
falling risk will be evaluated by the Tinetti performance oriented mobility assessment (POMA).
Balance section of Tinetti Performance Oriented Mobility Assessment (Tinetti Performance Oriented Mobility Assessment has two subscales, Balance and Gait section.)
Balance section has 9 items.
Each item can be scored in a 3 point ordinal scale (0-2).
"0" indicates the lowest level of function and "2" the highest level of function.
Total Score = 16.
Total score is obtained by adding the individual scores.
|
before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
difference in gait performance between experimental arm and control arm
Time Frame: before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
gait performance will be evaluated by the walking speed evaluated by instrumental gait analysis
|
before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
|
difference in fear of falling between experimental arm and control arm
Time Frame: before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
fear of falling will be evaluated by the Falls Efficacy Scale - International (FES-I).
Higher scores represent greater the fear of falling (ranging from 16 to 64)
|
before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
|
difference in quality of life between experimental arm and control arm: SF-12 health survey
Time Frame: before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
Quality of life will be measured using the Hausa SF-12 Health Survey (SF-12-H).
The questionnaire consists of 12 items questioned weighted and summed to provide physical and mental health scores (PCS and MCS).
The two composite scores are computed using the scores on twelve questions that range from 0 to 100, with higher score indicating better health
|
before treatment, at the end of rehabilitation sessions and 6 months, 12 months and 24 months after intervention
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- INRCA-01-2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Technological intervention arm
-
National Healthcare Group, SingaporeSingapore General Hospital; Nanyang Technological University; Duke-NUS Graduate...Recruiting
-
Ohio State UniversityNational Institute on Drug Abuse (NIDA)CompletedHypothetical Cannabis PurchaseUnited States
-
Akdeniz UniversityNot yet recruitingOlder Adults (65 Years and Older)Turkey (Türkiye)
-
IRCCS San Camillo, Venezia, ItalyRecruitingMotor Disorders | Neurological DiseaseItaly
-
UConn HealthNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Centre Leon BerardNational Cancer Institute, France; Fondation de France; Cancéropôle Lyon Auvergne... and other collaboratorsCompletedImpact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy (PASAPAS)Breast Cancer | Adequate Physical ConditionFrance
-
Jonsson Comprehensive Cancer CenterAmerican Cancer Society, Inc.Completed
-
Harvard School of Public Health (HSPH)Africa Academy for Public HealthNot yet recruiting
-
Heart of England NHS TrustAstraZenecaUnknown
-
Zhejiang UniversityShandong UniversityNot yet recruitingDementia | Cognitive FunctionChina